Orion Pharma Statistics

Total Valuation

Orion Pharma has a market cap or net worth of BDT 7.18 billion. The enterprise value is 31.85 billion.

Market Cap	7.18B
Enterprise Value	31.85B

Important Dates

The last earnings date was Wednesday, January 29, 2025.

Earnings Date	Jan 29, 2025
Ex-Dividend Date	Dec 5, 2024

Share Statistics

Orion Pharma has 234.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	234.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	25.83%
Owned by Institutions (%)	n/a
Float	84.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.97
PB Ratio	0.34
P/TBV Ratio	0.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 31.55, with an EV/FCF ratio of -424.97.

EV / Earnings	-1,990.97
EV / Sales	4.31
EV / EBITDA	31.55
EV / EBIT	47.31
EV / FCF	-424.97

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 1.04.

Current Ratio	1.99
Quick Ratio	1.71
Debt / Equity	1.04
Debt / EBITDA	23.31
Debt / FCF	-311.18
Interest Coverage	1.26

Financial Efficiency

Return on equity (ROE) is -0.19% and return on invested capital (ROIC) is 0.92%.

Return on Equity (ROE)	-0.19%
Return on Assets (ROA)	0.76%
Return on Invested Capital (ROIC)	0.92%
Return on Capital Employed (ROCE)	1.45%
Revenue Per Employee	2.34M
Profits Per Employee	-5,062
Employee Count	3,160
Asset Turnover	0.14
Inventory Turnover	3.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.30% in the last 52 weeks. The beta is -0.62, so Orion Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.62
52-Week Price Change	-60.30%
50-Day Moving Average	36.31
200-Day Moving Average	51.99
Relative Strength Index (RSI)	25.72
Average Volume (20 Days)	989,724

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Pharma had revenue of BDT 7.38 billion and -16.00 million in losses. Loss per share was -0.07.

Revenue	7.38B
Gross Profit	1.89B
Operating Income	664.15M
Pretax Income	135.78M
Net Income	-16.00M
EBITDA	991.87M
EBIT	664.15M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 148.26 million in cash and 23.32 billion in debt, giving a net cash position of -23.16 billion or -98.97 per share.

Cash & Cash Equivalents	148.26M
Total Debt	23.32B
Net Cash	-23.16B
Net Cash Per Share	-98.97
Equity (Book Value)	22.52B
Book Value Per Share	89.82
Working Capital	8.48B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.96 billion and capital expenditures -2.03 billion, giving a free cash flow of -74.94 million.

Operating Cash Flow	1.96B
Capital Expenditures	-2.03B
Free Cash Flow	-74.94M
FCF Per Share	-0.32

Full Cash Flow Statement

Margins

Gross margin is 25.63%, with operating and profit margins of 9.00% and -0.22%.

Gross Margin	25.63%
Operating Margin	9.00%
Pretax Margin	1.84%
Profit Margin	-0.22%
EBITDA Margin	13.44%
EBIT Margin	9.00%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 3.19%.

Dividend Per Share	1.00
Dividend Yield	3.19%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	3.19%
Earnings Yield	-0.22%
FCF Yield	-1.04%

Dividend Details

Stock Splits

The last stock split was on May 27, 2013. It was a forward split with a ratio of 1.2.

Last Split Date	May 27, 2013
Split Type	Forward
Split Ratio	1.2

Scores

Orion Pharma has an Altman Z-Score of 0.82. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.82
Piotroski F-Score	n/a